Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling

Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor α-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF<sup>mNTS</sup> neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF<sup>mNTS</sup> neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-12-30
DOI
https://doi.org/10.1038/s41467-024-54367-y
Citations
7
Primary Topic
GDF15 and Related Biomarkers
Type
article
Field-Weighted Citation Impact
3.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling

Mehdi Boutagouga Boudjadja, Simon M. Luckman, Rosemary Shoop, Claire H. Feetham et al.
7 citations
Nature Communications
GDF15 and Related Biomarkers
3.29
article

Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling

Mehdi Boutagouga Boudjadja, Simon M. Luckman, Rosemary Shoop, Claire H. Feetham, Amy A. Worth, Paul J. Emmerson, Tamer Coşkun, Court Harding, Sam Groom, Giuseppe D’Agostino, Valeria Collabolletta
article en
7 citations

Abstract

Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor α-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF<sup>mNTS</sup> neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF<sup>mNTS</sup> neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.

Nature CommunicationsVol. 15(1)
Eli Lilly (United States) (US), University of Manchester (GB)
Eli Lilly and Company, Directorate for Biological Sciences, Medical Research Council, Biotechnology and Biological Sciences Research Council
Zero hunger
Openalex Percentile: Top 7%
GDF15 and Related Biomarkers
3.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.